Name | Recombinant Human FLRG Protein |
---|---|
Supplier | R&D Systems |
Catalog | 1288-F3 |
Category | Protein |
Prices | $329.00 |
Sizes | 25 µg |
Species Reactivities | Human |
Nature | Recombinant |
Source | Mouse myeloma cell line, NS0-derived Met27-Val263, with a C-terminal 6-His tag |
Purity | >90%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Bioactivity | Measured by its ability to neutralize Activin-mediated erythroid differentiation of K562 human chronic myelogenous leukemia cells. The ED 50 for this effect is 3-15 ng/mL in the presence of 7.5 ng/mL recombinant human Activin A. |
Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
SwissProt/Accession | O95633 |
Gene | FSTL3 |
Sequence | Met27 |
Supplier Page | Shop |
Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH. Prenat Diagn. 2011 Feb;31(2):135-41.
Miron P, Lambert J, Marcil A, Cowans NJ, Stamatopoulou A, Spencer K. Prenat Diagn. 2010 Mar;30(3):224-8.
Jeanpierre S, Nicolini FE, Kaniewski B, Dumontet C, Rimokh R, Puisieux A, Maguer-Satta V. Blood. 2008 Oct 15;112(8):3154-63.
Butler GS, Dean RA, Tam EM, Overall CM. Mol Cell Biol. 2008 Aug;28(15):4896-914.